🔎 Trials Near Me

Akèy › BPCO › Pennsylvania › Philadelphia

Etid klinik pou BPCO nan Philadelphia, PA

23 etid pou BPCO ap chèche patisipan nan sit nan ak bò kote Philadelphia (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Ap rekriteFaz 3
  • Research Site, Philadelphia
  • Research Site, Philadelphia
Laj 40 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Ap rekriteFaz 3
  • Suburban Research Associates - Media- Site Number : 8400143, Media · 12 mi lwen
Laj 40 a 80 · Tout sèks · Mizajou Oct 1, 2026 · NCT07190222

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Ap rekriteFaz 2
  • DM Clinical Research - Philadelphia, Philadelphia
Laj 40 a 85 · Tout sèks · Mizajou Sep 30, 2026 · NCT07684820

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Ap rekrite
  • Penn Medicine, Philadelphia
  • Temple University, Philadelphia
Laj 40 a 80 · Tout sèks · Mizajou Sep 17, 2026 · NCT06035120

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Ap rekriteFaz 2
  • Research Site, Philadelphia
  • Research Site, Philadelphia
Laj 40 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Ap rekriteFaz 2
  • Temple University, Philadelphia
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Ap rekriteFaz 3
  • Research Site, Horsham · 16 mi lwen
  • Research Site, Wilmington · 25 mi lwen
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Ap rekriteFaz 3
  • Research Site, Philadelphia
Laj 40 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06883305

COPD Exacerbation Follow Up

Ap rekriteEtid obsèvasyon
  • Thomas Jefferson University, Philadelphia
Laj 40 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07118306

STRIVE Post-Market Registry Study

Ap rekriteEtid obsèvasyon
  • Temple University, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Ap rekriteFaz 3
  • GSK Investigational Site, West Chester · 24 mi lwen
Laj 40 a 75 · Tout sèks · Mizajou Jul 28, 2026 · NCT07177339

Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital

Ap rekrite
  • Temple University Hospital, Philadelphia
Laj 22 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT07222410

SPIROMICS Study of Early COPD Progression (SOURCE)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Temple University, Philadelphia
Laj 30 a 55 · Tout sèks · Mizajou Jun 3, 2026 · NCT05033990

Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

Ap rekrite
  • Temple University - Temple Lung Center, Philadelphia
Laj 40 a 80 · Tout sèks · Mizajou Apr 28, 2026 · NCT07051707

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Ap rekrite
  • Temple University, Philadelphia
Laj 40 a 84 · Tout sèks · Mizajou Apr 24, 2026 · NCT06891755

Feasibility of Semaglutide in Advanced Lung Disease

Ap rekriteFaz 1/2
  • University of Pennsylvania Perelman School of Medicine, Philadelphia
Laj 18 a 80 · Tout sèks · Mizajou Apr 21, 2026 · NCT05746039

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Ap rekriteFaz 3
  • GSK Investigational Site, Philadelphia
Laj 40 a 80 · Tout sèks · Mizajou Apr 9, 2026 · NCT06961214

Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry

Ap rekriteEtid obsèvasyon
  • Thomas Jefferson University, Philadelphia
Laj 50 a 80 · Tout sèks · Mizajou Mar 3, 2026 · NCT06974981

Supporting Evidence-based Responses to Emotional Needs in Emphysema

Ap rekrite
  • University of Pennsylvania, Philadelphia
Laj 18 ak plis · Tout sèks · Mizajou Jan 30, 2026 · NCT06600126

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Ap rekriteEtid obsèvasyon
  • Temple University, Philadelphia
Laj 50 ak plis · Tout sèks · Mizajou Aug 5, 2025 · NCT06122077

Temple Health Chest Initiative (THCI 2.0)

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Temple University Of the Commonwealth System of Higher Education, Philadelphia
Laj 50 a 80 · Tout sèks · Mizajou Apr 18, 2025 · NCT06933758

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Ap rekrite
  • Jeanes Hospital, Philadelphia
  • Temple University, Philadelphia
Laj 30 ak plis · Tout sèks · Mizajou Feb 6, 2025 · NCT05204888

Etid BPCO nan lòt vil

Lòt etid nan Philadelphia

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.